CE Marking is mandatory for every medical device sold within the EU and the European Economic Area (EEA), making it an essential certification requirement for companies aiming to access this lucrative market. Renowned and highly sought after, the CE Mark holds a unique position in the global medical devices trade. CE-marked products often enjoy easier entry into other regulated markets, such as Australia, the Middle East, India, and parts of Asia, where CE compliance is regarded as a benchmark of quality and safety. Beyond regulatory compliance, the CE Mark also serves as a powerful marketing tool, building trust among stakeholders and boosting market share in competitive regions.

Medical device manufacturers planning to enter or continue selling in the European Union (EU) with CE Marking often find it very challenging after the release of the regulation MDR 2017/745. This is due to stricter documentation requirements, the limited availability of Notified Bodies, the exorbitant fee hikes by Notified Bodies and the availability of experienced internal resources. Under the new MDR, manufacturers must provide detailed technical documentation, robust clinical evidence, and post-market surveillance data to secure or maintain CE certification. These changes replace the more lenient framework of the previous Medical Device Directive (MDD), creating additional hurdles for manufacturers aiming for EC Certification.